A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
AbbVie
AbbVie
AbbVie
Corcept Therapeutics
Ohio State University Comprehensive Cancer Center
Lebanese University
M.D. Anderson Cancer Center
Genelux Corporation
Ohio State University Comprehensive Cancer Center
University of Pittsburgh
Massachusetts General Hospital